Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
9.28
-0.08 (-0.85%)
At close: Jan 16, 2026, 4:00 PM EST
9.29
+0.01 (0.11%)
After-hours: Jan 16, 2026, 5:16 PM EST
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $528.62 million as of January 16, 2026. Its market cap has increased by 51.32% in one year.
Market Cap
528.62M
Enterprise Value
324.40M
1-Year Change
51.32%
Ranking
Category
Stock Price
$9.28
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $528.62M, a decrease of -76.04%. That is a compound annual growth rate of -25.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 528.62M | -1.07% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | 2.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |